See the DrugPatentWatch profile for cosentyx

The typical dosage of Cosentyx (secukinumab) for ankylosing spondylitis is 150mg, injected once a week for the first 4 weeks, and then every 4 weeks thereafter [1]. However, it is important to note that the dosage may vary depending on the individual's response to treatment and as determined by the prescribing physician.

It is also important to follow the instructions provided by the manufacturer for the proper administration of Cosentyx. This includes injecting the full amount of medication in a single injection, using a new prefilled syringe or autoinjector for each dose, and injecting the medication subcutaneously (under the skin) in the thigh, abdomen, or upper arm [1].

It is worth noting that, according to DrugPatentWatch.com, Cosentyx is a medication that is still under patent protection, which means that generic versions of the drug are not yet available on the market [2].

In summary, the typical dosage of Cosentyx for ankylosing spondylitis is 150mg injected once a week for the first 4 weeks, and then every 4 weeks thereafter. However, it is important to follow the instructions provided by the manufacturer and consult with a healthcare professional for proper administration and dosage.

Sources:

* [1] Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
* [2] Secukinumab. DrugPatentWatch.com. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>